|
Index of reports
> Hospitalization (41)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Arzerra (Ofatumumab) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 41 Next >>
Possible Arzerra side effects in female
Reported by a physician from Italy on 2012-08-27
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Vomiting, Hypotension, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Dosage: 300mg cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-20
Cyclophosphamide
Dosage: 600mgm2 cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-19
Losazid
Dosage: 50mg twice per day
Administration route: Oral
Indication: Hypertension
Start date: 2009-03-29
End date: 2012-07-25
Nipent
Dosage: 2mgm2 cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-07-19
Other drugs received by patient: Allopurinol; Sulfamethoxazole and Trimethoprim
Possible Arzerra side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: Hypertension, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 74 year old female
Reported by a physician from United States on 2012-08-16
Patient: 74 year old female, weighing 75.9 kg (167.0 pounds)
Reactions: Blood Culture Positive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Dosage: 2000mg cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-06-19
Campath
Dosage: 30mg weekly
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-06-05
Other drugs received by patient: Mirtazapine; Esomeprazole Magnesium; Humalog; Prochlorperazine; Alprazolam; Fluconazole; Rosuvastatin; Ramipril; Pentamidine Isethionate; Estradiol; Nepafenac; Ferrous Sulfate TAB; Pred Forte; Lantus; Acyclovir; Cyanocobalamin + Folic Acid + Pyridoxine Hydrochloride; Vesicare
Possible Arzerra side effects in male
Reported by a physician from United Kingdom on 2012-08-16
Patient: male, weighing 62.4 kg (137.3 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-05-31
Bendamustine Hydrochloride
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-05-31
Prednisolone
Dosage: 20mg as required
Administration route: Oral
Start date: 2012-05-31
Other drugs received by patient: Metoclopramide; Chlorpheniramine Maleate; Allopurinol; Acyclovir; Acetaminophen; Neupogen
Possible Arzerra side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11
Patient:
Reactions: Product Quality Issue, Anaphylactic Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Unknown
Possible Arzerra side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-09
Patient: female
Reactions: Neck Pain, Abasia, Oropharyngeal Pain, Infusion Related Reaction
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Revlimid
Possible Arzerra side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-06-27
Patient: 75 year old male
Reactions: White Blood Cell Count Decreased, Cardiac Failure, Haemorrhage, Platelet Count Decreased, Acute Respiratory Distress Syndrome, Pyrexia, Neutrophil Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-06-19
Patient: 75 year old male
Reactions: White Blood Cell Count Decreased, Haemorrhage, Platelet Count Decreased, Pyrexia, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in male
Reported by a health professional (non-physician/pharmacist) from Greece on 2012-06-12
Patient: male
Reactions: White Blood Cell Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in
Reported by a consumer/non-health professional from United States on 2012-06-05
Patient:
Reactions: Diarrhoea, Pyrexia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 63 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04
Patient: 63 year old female, weighing 93.6 kg (205.9 pounds)
Reactions: Diarrhoea, Mental Status Changes, Gait Disturbance, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Venlafaxine; Atenolol; Loperamide; Mepron; Zomig; Compazine; Levaquin; Azithromycin
Possible Arzerra side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24
Patient: male
Reactions: Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 63 year old female
Reported by a consumer/non-health professional from United States on 2012-05-18
Patient: 63 year old female, weighing 93.6 kg (205.9 pounds)
Reactions: Diarrhoea, Mental Status Changes, Gait Disturbance, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 51 year old male
Reported by a pharmacist from United States on 2012-05-16
Patient: 51 year old male
Reactions: Febrile Neutropenia, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Bactrim; Atovaquone; Levofloxacin; Allopurinol; Fluconazole; Acyclovir
Possible Arzerra side effects in 63 year old male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: 63 year old male, weighing 55.9 kg (123.0 pounds)
Reactions: Productive Cough, Cellulitis, Alanine Aminotransferase Increased, Flatulence, Intestinal Obstruction, Abdominal Pain Upper, Small Intestinal Obstruction, Volvulus, Malaise, Intestinal Dilatation, Diarrhoea, Abdominal Distension, Gastrointestinal Sounds Abnormal, Septic Shock, Asthenia
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Mucinex; Flomax; Imodium; Decadron; Allegra; Acidophilus; Temazepam
Possible Arzerra side effects in male
Reported by a physician from Slovenia on 2012-04-30
Patient: male
Reactions: Lymphadenopathy, Drug Ineffective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in male
Reported by a physician from Slovenia on 2012-04-26
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in male
Reported by a physician from Slovenia on 2012-04-24
Patient: male
Reactions: Lymphadenopathy, Drug Ineffective, Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-16
Patient: 62 year old female, weighing 81.7 kg (179.7 pounds)
Reactions: Pneumonia Viral, Hypoxia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Other drugs received by patient: Potassium Chloride; Azithromycin; Venlafaxine; Compazine; Zomig; Ambien; Levaquin; Loperamide; Atenolol; Clonazepam; Gabapentin; Mepron; Lorazepam; Vesicare; Benadryl; Ferrous Gluconate
Possible Arzerra side effects in 69 year old male
Reported by a physician from Greece on 2012-03-09
Patient: 69 year old male
Reactions: Hepatomegaly, Splenomegaly, Respiratory Tract Infection, Herpes Virus Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in female
Reported by a physician from Netherlands on 2012-02-21
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Oral Pain, Pyrexia, Arthritis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in 71 year old male
Reported by a physician from United States on 2012-02-17
Patient: 71 year old male, weighing 83.6 kg (183.9 pounds)
Reactions: Pneumonia, Acute Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Arzerra
Dosage: 1000mgm2 weekly
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-02-02
Methylprednisolone
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-02-03
Other drugs received by patient: Multi-Vitamin; Valacyclovir; Antibiotic; Allopurinol; Calcium Carbonate + Vitamin D; Septra; Folic Acid; Ascorbic Acid; Bactrim
Possible Arzerra side effects in female
Reported by a physician from Sweden on 2012-02-16
Patient: female, weighing 71.8 kg (158.0 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alemtuzumab
Dosage: 30mg three times per week
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-26
Arzerra
Dosage: 2000mg cyclic
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-24
End date: 2012-01-30
Valganciclovir HCL
Indication: Product Used FOR Unknown Indication
Possible Arzerra side effects in female
Reported by a physician from Ukraine on 2012-02-14
Patient: female, weighing 59.0 kg (129.8 pounds)
Reactions: Anaemia Haemolytic Autoimmune
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-20
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-20
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-09-20
Possible Arzerra side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-14
Patient: 62 year old female, weighing 81.7 kg (179.7 pounds)
Reactions: Pneumonia Viral, Hypoxia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Possible Arzerra side effects in male
Reported by a physician from United Kingdom on 2012-02-13
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Confusional State, Lower Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Dosage: 300mg cyclic
Indication: Richter's Syndrome
Start date: 2011-10-11
Cyclophosphamide
Dosage: 700mg cyclic
Indication: Richter's Syndrome
Start date: 2011-10-11
Doxorubicin HCL
Dosage: 46mg cyclic
Indication: Richter's Syndrome
Start date: 2011-10-11
Prednisolone
Dosage: 75mg cyclic
Administration route: Oral
Indication: Richter's Syndrome
Start date: 2011-10-11
Vincristine
Dosage: 1mg cyclic
Indication: Richter's Syndrome
Start date: 2011-10-11
Possible Arzerra side effects in male
Reported by a physician from Korea, Republic of on 2012-02-13
Patient: male, weighing 53.2 kg (117.0 pounds)
Reactions: Pneumonia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-08
Carboplatin
Dosage: 410mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-08
Etoposide
Dosage: 144mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-08
Ifosfamide
Dosage: 2400mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-08
Other drugs received by patient: Mesna
Possible Arzerra side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-13
Patient: 56 year old male, weighing 73.5 kg (161.7 pounds)
Reactions: Transaminases Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arzerra
Dosage: 1000mg weekly
Indication: Leukaemia
Start date: 2011-08-11
End date: 2011-08-31
Investigational Study Drug
Dosage: 150mg twice per day
Administration route: Oral
Indication: Leukaemia
Start date: 2011-08-10
End date: 2011-10-14
Possible Arzerra side effects in female
Reported by a physician from Greece on 2012-02-08
Patient: female, weighing 64.5 kg (141.9 pounds)
Reactions: Haemolytic Anaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Arzerra
Indication: non-Hodgkin's Lymphoma
Start date: 2011-03-31
Bendamustine
Indication: non-Hodgkin's Lymphoma
Start date: 2011-03-31
Possible Arzerra side effects in male
Reported by a physician from Brazil on 2012-02-07
Patient: male, weighing 70.2 kg (154.4 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Arzerra
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-05-25
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-05-25
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-05-25
Page 1 Next >>
|
